NCT01990534 2021-04-09A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaTakedaPhase 4 Completed60 enrolled 21 charts
NCT02670564 2019-04-16ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)Swiss Pediatric Oncology GroupPhase 4 Recruiting1,000 enrolled